Cytokinetics, Incorporated (NASDAQ:CYTK) Director Sells $76,851.20 in Stock

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director Robert Arthur Harrington sold 1,580 shares of the company’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $48.64, for a total value of $76,851.20. Following the transaction, the director now directly owns 15,541 shares in the company, valued […]

Related Keywords

,Raymond James ,Robert Arthur Harrington ,Cetera Advisors ,Murchinson Ltd ,Securities Exchange Commission ,Castleark Management ,Comerica Bank ,Barclays ,Nasdaq ,Cytokinetics Incorporated ,Get Free Report ,Director Robert Arthur Harrington ,Exchange Commission ,Cytokinetics Daily ,